High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.
Impact in
Classified as
- Journal
- PubMed
In The Last Decade
doi.org/w32906648 →Countries where authors are citing High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.
This map shows the geographic impact of High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. more than expected).
Fields of papers citing High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.
This network shows the impact of High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules..
About High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.
This paper, published in 2001, received 507 indexed citations . Written by Gregory P. Adams, Robert Schier, Adrian M. McCall, Heidi H. Simmons, Eva Horak, R. Katherine Alpaugh, James D. Marks and L M Weiner covering the research area of Molecular Biology and Radiology, Nuclear Medicine and Imaging. It is primarily cited by scholars working on Radiology, Nuclear Medicine and Imaging (306 citations), Molecular Biology (251 citations), Oncology (163 citations), Biomaterials (85 citations) and Immunology (72 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w32906648.